Investor Overview | May 2026 | Seed Round
Advanced prosthetic systems for augmented human capability.
Genesis Dynamics is the prosthetics-centered brand of Project Genesis, the first operating program at HuMod. The company is building integrated systems that combine hardware, embedded intelligence, and clinical-grade manufacturing into one stack.
Launch thesis
Powered capability, priced for clinical adoption.
2M
Americans living with lower-limb loss
<1%
Powered ankle adoption today
~80%
Target gross margin profile
Summary
Built to win the U.S. lower-limb market.
Genesis Dynamics carries HuMod's prosthetics work to market: engineered to win the U.S. lower-limb category on day-one economics, with a broader stack designed to scale beyond it.
The platform enters at the highest reimbursement tier and expands outward on the same technical foundation, treating prosthetics, robotics, and human-interface systems as one integrated design problem.
The Genesis Stack
Device, intelligence, and clinical workflow.
A vertically integrated deployment platform for lower-limb prosthetics, built around coordinated assets rather than a single device.
Genesis Ankle
The first product: a powered, microprocessor-controlled lower-limb prosthetic for K3-K4 amputees.
Genesis BK System
The shared device architecture for follow-on platforms and adjacent lower-limb segments.
Genesis Foundry
The manufacturing and clinical-workflow layer that takes patient scans through delivered systems.
Market
A large category still waiting for powered adoption.
Lower-limb loss
2M
Americans live with lower-limb loss, with the population growing as diabetes and vascular disease drive amputation rates higher.
Powered adoption
<1%
Fewer than 1% walk on a powered prosthetic ankle today, leaving a large gap between clinical possibility and actual delivery.
Gross margin
~80%
Engineered for strong day-one unit economics at a wholesale price point designed to create channel pull from launch.
Genesis Ankle
First product built for reimbursement leverage.
The Genesis Ankle targets K3-K4 amputees at the center of the U.S. lower-limb market. It bills under L5973 with stacking eligibility under L5969, the target of the PDAC submission this quarter.
Traction
- Genesis Ankle built and in preproduction; manufacturing capability online for initial units
- 510(k) exempt: no premarket clearance required
- PDAC Coding Verification Review submission targeted this quarter
- Patent coverage across core system components
- Inbound demand from clinics and direct customers
Seed Round
Round details
Use of funds: complete PDAC submission and coding verification, initiate first commercial clinical deployments, and stand up Foundry operations for the early customer cohort.
Target
$1.5M SAFE
Valuation cap
$30M
Closed
$545K
36% of seed target
Next Step
Request access to the HuMod vault.
Share your contact information and we'll follow up with access to restricted updates, presentations, technical resources, and diligence materials.